miércoles, 20 de enero de 2016

CDER's Latest "From our perspective" by Richard Pazdur, M.D.

Expedited oncology drug approvals
In this article, Dr. Richard Pazdur highlights some of the 2015 approvals from the Office of Hematology and Oncology Products and discusses a few of the expedited review programs used by the office.
From our perspective logo

No hay comentarios: